Erratum: Author Correction: Sustained NF-κB-STAT3 signaling promotes resistance to Smac mimetics in Glioma stem-like cells but creates a vulnerability to EZH2 inhibition

Cintia Carla da Hora; Kelsey Pinkham; Litia Carvalho; Max Zinter; Elie Tabet; Ichiro Nakano; Bakhos A Tannous; Christian E Badr

doi:10.1038/s41420-019-0183-5

Erratum: Author Correction: Sustained NF-κB-STAT3 signaling promotes resistance to Smac mimetics in Glioma stem-like cells but creates a vulnerability to EZH2 inhibition

Cell Death Discov. 2019 Jun 17:5:103. doi: 10.1038/s41420-019-0183-5. eCollection 2019.

Authors

Cintia Carla da Hora^{1

2

3}, Kelsey Pinkham¹, Litia Carvalho^{1

2

3}, Max Zinter^{1

3}, Elie Tabet^{1

3}, Ichiro Nakano⁴, Bakhos A Tannous^#^{1

2

3}, Christian E Badr^#^{1

2}

Affiliations

¹ 1Department of Neurology, Massachusetts General Hospital, Boston, MA USA.
² 2Neuroscience Program, Harvard Medical School, Boston, MA USA.
³ Experimental Therapeutics and Molecular Imaging Laboratory, Charlestown, MA USA.
⁴ 4Department of Neurosurgery and Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL USA.

^# Contributed equally.

Abstract

[This corrects the article DOI: 10.1038/s41420-019-0155-9.].

Keywords: CNS cancer; Cancer stem cells.

Publication types

Published Erratum

Grants and funding

R01 NS107071/NS/NINDS NIH HHS/United States